Bismarck Lepe

Angel investor in San Francisco

Invests in AI

Bismarck Lepe's investor profile lists AI alongside Fintech, Healthcare & Biotech and Digital Health & HealthTech, at seed. The record holds 8 deals, among them PiSA Farmacéutica, Cerby and Farmacias del Ahorro.

Email Investor

Email Investor

Credits to line up before a seed round

Bismarck Lepe backs companies at seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • PiSA Farmacéutica
  • Cerby
  • Farmacias del Ahorro
  • Reserbus
  • CodeSignal
  • Tecnológico de Monterrey
  • Wizeline
  • Soccerly

Investment focus

Backs startups in
Artificial Intelligence, Fintech, Healthcare & Biotech, Digital Health & HealthTech, SaaS & Enterprise, Consumer & Retail and 3 more
Rounds
Seed
Profile
Angel investor
Deals on record
8
Based in
San Francisco, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Bismarck Lepe invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Bismarck Lepe's investor profile, together with Fintech, Healthcare & Biotech and Digital Health & HealthTech. The stages on record are seed.
Which companies has Bismarck Lepe backed?
The record lists 8 deals, including PiSA Farmacéutica, Cerby, Farmacias del Ahorro, Reserbus and CodeSignal. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Bismarck Lepe?
For a company raising a seed round, AI Perks lists credits such as Google Cloud (up to $350,000), Replit (up to $25,000), Aiven (up to $100,000) and IBM Cloud (up to $120,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor